Cauldron
Company Details
About: Founded in 2022, Cauldron is a global biomanufacturer on a mission to realize the full potential of precision fermentation by unlocking price parity for mainstream bio-manufactured goods. By solving historical continuous fermentation challenges to establish a scalable, repeatable continuous process, Cauldron aims to solve the gap in commercially viable biomanufacturing capacity. Developed over more than three decades of R&D, Cauldron's proprietary hyper-fermentation technology drives significant gains in productivity, generating more volume at less cost, using smaller bioreactors.
We're operating today at our commercial demo-facility in regional Australia and working with global clients across the precision fermentation industry to de-risk the path to commercialization.
Visit www.cauldronferm.com to learn more.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Cauldron | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.